A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780

Cell Growth and Differentiation

Volumn 7, Issue 11, 1996, Pages 1501-1506

  Huynh, Hung ^b   Yang, Xiao Feng ^a   Pollak, Michael ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTIESTROGEN; ANTISENSE OLIGODEOXYNUCLEOTIDE; DNA; ESTRADIOL; ESTROGEN; FULVESTRANT; MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BREAST NEOPLASMS; CARCINOGENS; CARCINOMA; CELL DIVISION; CULTURE MEDIA, CONDITIONED; ESTRADIOL; ESTROGEN ANTAGONISTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MAMMARY NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDES, ANTISENSE; RATS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0029959858     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H. L., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
2. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 16: 3-34, 1995.
3. Elgin, R. G., Busby, W. H., and Clemmons, D. R. An insulin-like growth factor (IGF) binding protein enhances the biological response to IGF-I. Proc. Natl. Acad. Sci. USA, 84: 3254-3258, 1987.
4. Rutanen, E. M., Pekonen, F., and Makinen, T. Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action. J. Clin. Endocrinol. Metab., 66: 173-180, 1988.
5. Kiefer, M. C., Schmid, C., Waldvogel, M., Schlapfer, I., Futo, E., Masiarz, F. R., Green, K., Barr, P. J., and Zapf, J. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J. Biol. Chem., 267: 12692-12699, 1992.
6. Oh, Y., Mullers, H. L., Ng, L., and Rosenfeld, R. G. Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem., 270: 13589-13592, 1995.
7. Huynh, H. T., Yang, X., and Pollak, M. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J. Biol. Chem., 271: 1016-1021, 1996.
8. Allander, S. V., Larsson, C., Ehrenborg, E., Suwanichkul, A., Weber, G., Morris, S. L., Bajalica, S., Kiefer, M. C., Luthman, H., and Powell, D. R. Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5. J. Biol. Chem., 269: 10891-10898, 1994.
9. Shimasaki, S., Shimonaka, M., Zhang, H., and Ling, N. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J. Biol. Chem., 266: 10646-10653, 1991.
10. Bautista, C. M., Baylink, D. J., and Mohan, S. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem. Biophys. Res. Commun., 176: 756-763, 1991.
11. Andress, D. L., and Birnbaum, R. S. A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells. Biochem. Biophys. Res. Commun., 176: 213-218, 1991.
12. Jones, J. I., Gockerman, A., Busby, W. H. J., Camacho-Hubner, C., and Clemmons, D. R. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-1. J. Cell Biol., 121: 679-687, 1993.
13. Andress, D. L., Loop, S. M., Zapf, J., and Kiefer, M. C. Carboxytruncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem. Biophys. Res. Comm., 195: 25-30, 1993.
14. Arai, T., Arai, A., Busby, W. H., Jr., and Clemmons, D. R. Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5. Endocrinology, 135: 2358-2363, 1994.
15. Reeve, J. G., Guadano, A., Xiong, J., Morgan, J., and Bleehen, N. M. Diminished expression of insulin-like growth factor (IGF) binding protein-5 and activation of IGF-I-mediated autocrine growth in simian virus 40-transformed human fibroblasts. J. Biol. Chem., 270: 135-142, 1995.
16. Pollak, M., Costantino, J., Polychronakos, C., Blauer, S., Guyda, H., Redmond, C., Fisher, B., and Margolese, R. Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients. J. Natl. Cancer Inst., 82: 1693-1697, 1990.
17. Huynh, H. T., Tetenes, E., Wallace, L., and Pollak, M. In vivo inhibition of insulin-like growth factor-I gene expression by tamoxifen. Cancer Res., 53: 1727-1730, 1993.
18. Pollak, M. Effects of adjuvant tamoxifen therapy on growth hormone and insulin-like growth factor I (IGF-I) physiology. In: S. E. Salmon (ed.), Adjuvant Therapy of Cancer VII, pp. 43-54. Philadelphia: J. B. Lippincott Company, 1993.
19. Wakeling, A. E., Dukes, M., and Bowler, J. A potent specific pure antiestrogen with clinical potential. Cancer Res., 51: 3867-3873, 1991.
20. Huynh, H. T., and Pollak, M. Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine IGF binding protein 3 gene expression. Cancer Res., 54: 3115-3119, 1994.
21. Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., and Dickson, R. B. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48: 417-428, 1987.
22. Nam, T. J., Busby, W. H., Jr., and Clemmons, D. R. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. Endocrinology, 135: 1385-1391, 1994.
23. Mohan, S., Nakao, Y., Honda, Y., Landale, E., Leser, U., Dony, C., Lang, K., and Baylink, D. J. Studies on the mechanisms by which insulin- like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J. Biol. Chem., 270: 20424-20431, 1995.
24. Jaques, G., Wegmann, B., Noll, K., Radulescu, R., and Havemann, K. Nuclear localization of IGFBP-3 in lung cancer cell lines. Third International Symposium on Insulin-like Growth Factor Binding Proteins (Tübingen, Germany), Abstract 3-28, 1995.
25. Conover, C. A., Bale, L. K., Clarkson, J. T., and Torring, O. Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells. Endocrinology, 132: 2525-2530, 1993.
26. Arteaga, C. L., Kitten, L. J., Coronado, E. B., Jacobs, S., Kull, F. C., Allred, D. C., and Osborne, C. K. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J. Clin. Invest., 84: 1418-1423, 1989.
27. Osborne, C. K., Coronado, E. B., Kitten, L. J., Arteaga, C. L., Fuqua, S. A., Ramasharma, K., Marshall, M., and Li, C. H. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol. Endocrinol., 3: 1701-1709, 1989.
28. Cullen, K. J., Lippman, M. E., Chow, D., Hill, S., Rosen, N., and Zwiebel, J. A. Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol. Endocrinol., 6: 91-100, 1992.
29. Jordan, V. C., and Murphy, C. S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr. Rev., 11: 578-611, 1990.
30. Welsch, C. W. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Muggins. Cancer Res., 45: 3415-3443, 1985.
31. Ausubel, E. F., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Current Protocols in Molecular Biology. Current Protocols, Green Publishing Associates, Inc. and John Wiley & Sons, Inc., 1993.